25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Universal Med Finl &
Buy, Hold or Sell?

Let's analyze Universal Med Finl & together

I guess you are interested in Universal Med Finl &. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Universal Med Finl &. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Universal Med Finl &

I send you an email if I find something interesting about Universal Med Finl &.

1. Quick Overview

1.1. Quick analysis of Universal Med Finl & (30 sec.)










1.2. What can you expect buying and holding a share of Universal Med Finl &? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.17
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
HK$11.59
Expected worth in 1 year
HK$22.37
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
HK$12.13
Return On Investment
252.7%

For what price can you sell your share?

Current Price per Share
HK$4.80
Expected price per share
HK$4.79 - HK$5.87
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Universal Med Finl & (5 min.)




Live pricePrice per Share (EOD)
HK$4.80
Intrinsic Value Per Share
HK$1.06 - HK$30.45
Total Value Per Share
HK$12.65 - HK$42.04

2.2. Growth of Universal Med Finl & (5 min.)




Is Universal Med Finl & growing?

Current yearPrevious yearGrowGrow %
How rich?$2.8b$2.1b$654.6m23.3%

How much money is Universal Med Finl & making?

Current yearPrevious yearGrowGrow %
Making money$270.9m$251.8m$19.1m7.1%
Net Profit Margin15.5%16.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Universal Med Finl & (5 min.)




2.4. Comparing to competitors in the Credit Services industry (5 min.)




  Industry Rankings (Credit Services)  


Richest
#29 / 243

Most Revenue
#20 / 243

Most Profit
#16 / 243
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Universal Med Finl &?

Welcome investor! Universal Med Finl &'s management wants to use your money to grow the business. In return you get a share of Universal Med Finl &.

First you should know what it really means to hold a share of Universal Med Finl &. And how you can make/lose money.

Speculation

The Price per Share of Universal Med Finl & is HK$4.8. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Universal Med Finl &.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Universal Med Finl &, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$11.59. Based on the TTM, the Book Value Change Per Share is HK$2.70 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.49 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.34 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Universal Med Finl &.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.143.0%0.143.0%0.132.7%0.122.5%0.091.9%
Usd Book Value Change Per Share0.357.2%0.357.2%0.061.3%0.153.1%0.142.9%
Usd Dividend Per Share0.040.9%0.040.9%0.040.9%0.040.8%0.020.5%
Usd Total Gains Per Share0.398.1%0.398.1%0.112.2%0.183.8%0.163.4%
Usd Price Per Share0.58-0.58-0.61-0.68-0.67-
Price to Earnings Ratio4.02-4.02-4.74-5.74-8.04-
Price-to-Total Gains Ratio1.48-1.48-5.76-10.04-8.98-
Price to Book Ratio0.39-0.39-0.53-0.61-0.93-
Price-to-Total Gains Ratio1.48-1.48-5.76-10.04-8.98-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.61632
Number of shares1622
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.04
Usd Book Value Change Per Share0.350.15
Usd Total Gains Per Share0.390.18
Gains per Quarter (1622 shares)631.50299.26
Gains per Year (1622 shares)2,526.001,197.06
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1281224525162399581187
25614491504247719172384
38426736756871628753581
4112289821009495438344778
514031122712620119347925975
616841347215146143157517172
719641571817672167067098369
822451796320198190976689566
9252520209227242147862610763
10280622454252502386958511960

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%10.01.00.090.9%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Universal Med Finl & compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.6952.6950%0.492+448%1.151+134%1.092+147%
Book Value Per Share--11.58811.5880%8.893+30%9.010+29%6.360+82%
Current Ratio--1.0211.0210%2.635-61%1.828-44%1.429-29%
Debt To Asset Ratio--0.7460.7460%0.797-6%0.771-3%0.782-5%
Debt To Equity Ratio--3.4573.4570%3.918-12%3.768-8%3.875-11%
Dividend Per Share--0.3370.3370%0.330+2%0.286+18%0.192+75%
Eps--1.1161.1160%0.999+12%0.949+18%0.712+57%
Free Cash Flow Per Share--2.3312.3310%0.824+183%0.040+5665%-1.271+155%
Free Cash Flow To Equity Per Share--2.3312.3310%-0.066+103%0.474+391%0.345+577%
Gross Profit Margin--1.0001.0000%1.0000%0.906+10%0.803+25%
Intrinsic Value_10Y_max--30.448--------
Intrinsic Value_10Y_min--1.059--------
Intrinsic Value_1Y_max--1.220--------
Intrinsic Value_1Y_min--0.058--------
Intrinsic Value_3Y_max--5.061--------
Intrinsic Value_3Y_min--0.216--------
Intrinsic Value_5Y_max--10.585--------
Intrinsic Value_5Y_min--0.420--------
Market Cap9079391846.400+6%8493014456.3208493014456.3200%8965899448.320-5%10044077230.080-15%9896537112.576-14%
Net Profit Margin--0.1550.1550%0.165-6%0.191-19%0.252-39%
Operating Margin----0%-0%0.134-100%0.282-100%
Operating Ratio--1.4281.4280%1.342+6%1.187+20%0.879+63%
Pb Ratio0.414+6%0.3870.3870%0.533-27%0.608-36%0.932-58%
Pe Ratio4.302+6%4.0244.0240%4.744-15%5.743-30%8.038-50%
Price Per Share4.800+6%4.4904.4900%4.740-5%5.310-15%5.232-14%
Price To Free Cash Flow Ratio2.059+6%1.9261.9260%5.749-66%-2.076+208%-2.142+211%
Price To Total Gains Ratio1.583+6%1.4811.4810%5.765-74%10.039-85%8.978-84%
Quick Ratio--0.8570.8570%1.003-15%1.678-49%2.247-62%
Return On Assets--0.0240.0240%0.024+3%0.025-3%0.026-6%
Return On Equity--0.1130.1130%0.117-3%0.123-8%0.129-12%
Total Gains Per Share--3.0323.0320%0.822+269%1.437+111%1.285+136%
Usd Book Value--2814527537.7092814527537.7090%2159890269.778+30%2188196283.641+29%1544698794.412+82%
Usd Book Value Change Per Share--0.3460.3460%0.063+448%0.148+134%0.140+147%
Usd Book Value Per Share--1.4881.4880%1.142+30%1.157+29%0.817+82%
Usd Dividend Per Share--0.0430.0430%0.042+2%0.037+18%0.025+75%
Usd Eps--0.1430.1430%0.128+12%0.122+18%0.091+57%
Usd Free Cash Flow--566158416.059566158416.0590%200243241.248+183%9820493.834+5665%-308773266.412+155%
Usd Free Cash Flow Per Share--0.2990.2990%0.106+183%0.005+5665%-0.163+155%
Usd Free Cash Flow To Equity Per Share--0.2990.2990%-0.009+103%0.061+391%0.044+577%
Usd Market Cap1165793913.078+6%1090503056.1911090503056.1910%1151221489.164-5%1289659516.342-15%1270715365.255-14%
Usd Price Per Share0.616+6%0.5770.5770%0.609-5%0.682-15%0.672-14%
Usd Profit--270967270.800270967270.8000%251845686.000+8%240235244.400+13%177747458.400+52%
Usd Revenue--1752686065.2001752686065.2000%1529518776.000+15%1304889164.880+34%834293534.880+110%
Usd Total Gains Per Share--0.3890.3890%0.106+269%0.185+111%0.165+136%
 EOD+4 -4MRQTTM+0 -0YOY+25 -95Y+24 -1210Y+24 -12

3.3 Fundamental Score

Let's check the fundamental score of Universal Med Finl & based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-154.302
Price to Book Ratio (EOD)Between0-10.414
Net Profit Margin (MRQ)Greater than00.155
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.857
Current Ratio (MRQ)Greater than11.021
Debt to Asset Ratio (MRQ)Less than10.746
Debt to Equity Ratio (MRQ)Less than13.457
Return on Equity (MRQ)Greater than0.150.113
Return on Assets (MRQ)Greater than0.050.024
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Universal Med Finl & based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.292
Ma 20Greater thanMa 504.954
Ma 50Greater thanMa 1004.844
Ma 100Greater thanMa 2004.600
OpenGreater thanClose4.890
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Universal Med Finl &

Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People's Republic of China. It operates in two segments, Finance Business and Healthcare Business. The Finance Business segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. The Healthcare Business segment engages in medical and healthcare services; hospital operation; import, export, and domestic trading of medical-related goods; equipment life cycle management; and medical digitalization services. The company is also involved in medical technology services; hospital construction and management services; and medical consulting services. It serves its products to patients, hospitals, medical equipment suppliers, and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China. Genertec Universal Medical Group Company Limited operates as a subsidiary of China General Technology (Group) Holding Co.,Ltd.

Fundamental data was last updated by Penke on 2024-10-29 13:11:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Universal Med Finl & earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Universal Med Finl & to the Credit Services industry mean.
  • A Net Profit Margin of 15.5% means that $0.15 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Universal Med Finl &:

  • The MRQ is 15.5%. The company is making a huge profit. +2
  • The TTM is 15.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ15.5%TTM15.5%0.0%
TTM15.5%YOY16.5%-1.0%
TTM15.5%5Y19.1%-3.6%
5Y19.1%10Y25.2%-6.1%
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ15.5%12.1%+3.4%
TTM15.5%12.4%+3.1%
YOY16.5%15.6%+0.9%
5Y19.1%15.3%+3.8%
10Y25.2%15.1%+10.1%
4.3.1.2. Return on Assets

Shows how efficient Universal Med Finl & is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Universal Med Finl & to the Credit Services industry mean.
  • 2.4% Return on Assets means that Universal Med Finl & generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Universal Med Finl &:

  • The MRQ is 2.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.4%TTM2.4%0.0%
TTM2.4%YOY2.4%+0.1%
TTM2.4%5Y2.5%-0.1%
5Y2.5%10Y2.6%-0.1%
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4%0.9%+1.5%
TTM2.4%0.9%+1.5%
YOY2.4%0.9%+1.5%
5Y2.5%0.9%+1.6%
10Y2.6%0.8%+1.8%
4.3.1.3. Return on Equity

Shows how efficient Universal Med Finl & is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Universal Med Finl & to the Credit Services industry mean.
  • 11.3% Return on Equity means Universal Med Finl & generated $0.11 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Universal Med Finl &:

  • The MRQ is 11.3%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.3%TTM11.3%0.0%
TTM11.3%YOY11.7%-0.4%
TTM11.3%5Y12.3%-1.0%
5Y12.3%10Y12.9%-0.5%
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ11.3%2.9%+8.4%
TTM11.3%3.2%+8.1%
YOY11.7%3.7%+8.0%
5Y12.3%3.1%+9.2%
10Y12.9%3.6%+9.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Universal Med Finl &.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Universal Med Finl & is operating .

  • Measures how much profit Universal Med Finl & makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Universal Med Finl & to the Credit Services industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Universal Med Finl &:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y13.4%-13.4%
5Y13.4%10Y28.2%-14.8%
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.1%-18.1%
TTM-17.2%-17.2%
YOY-18.4%-18.4%
5Y13.4%15.4%-2.0%
10Y28.2%21.6%+6.6%
4.3.2.2. Operating Ratio

Measures how efficient Universal Med Finl & is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Credit Services industry mean).
  • An Operation Ratio of 1.43 means that the operating costs are $1.43 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Universal Med Finl &:

  • The MRQ is 1.428. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.428. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.428TTM1.4280.000
TTM1.428YOY1.342+0.086
TTM1.4285Y1.187+0.241
5Y1.18710Y0.879+0.308
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4280.799+0.629
TTM1.4280.762+0.666
YOY1.3420.823+0.519
5Y1.1870.751+0.436
10Y0.8790.769+0.110
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Universal Med Finl &.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Universal Med Finl & is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Credit Services industry mean).
  • A Current Ratio of 1.02 means the company has $1.02 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Universal Med Finl &:

  • The MRQ is 1.021. The company is just able to pay all its short-term debts.
  • The TTM is 1.021. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.021TTM1.0210.000
TTM1.021YOY2.635-1.614
TTM1.0215Y1.828-0.807
5Y1.82810Y1.429+0.399
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0212.078-1.057
TTM1.0212.389-1.368
YOY2.6353.156-0.521
5Y1.8283.975-2.147
10Y1.4294.715-3.286
4.4.3.2. Quick Ratio

Measures if Universal Med Finl & is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Universal Med Finl & to the Credit Services industry mean.
  • A Quick Ratio of 0.86 means the company can pay off $0.86 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Universal Med Finl &:

  • The MRQ is 0.857. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.857. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.857TTM0.8570.000
TTM0.857YOY1.003-0.146
TTM0.8575Y1.678-0.821
5Y1.67810Y2.247-0.569
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8571.550-0.693
TTM0.8572.131-1.274
YOY1.0032.476-1.473
5Y1.6784.384-2.706
10Y2.2474.712-2.465
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Universal Med Finl &.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Universal Med Finl & assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Universal Med Finl & to Credit Services industry mean.
  • A Debt to Asset Ratio of 0.75 means that Universal Med Finl & assets are financed with 74.6% credit (debt) and the remaining percentage (100% - 74.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Universal Med Finl &:

  • The MRQ is 0.746. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.746. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.746TTM0.7460.000
TTM0.746YOY0.797-0.050
TTM0.7465Y0.771-0.025
5Y0.77110Y0.782-0.011
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7460.710+0.036
TTM0.7460.709+0.037
YOY0.7970.696+0.101
5Y0.7710.707+0.064
10Y0.7820.689+0.093
4.5.4.2. Debt to Equity Ratio

Measures if Universal Med Finl & is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Universal Med Finl & to the Credit Services industry mean.
  • A Debt to Equity ratio of 345.7% means that company has $3.46 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Universal Med Finl &:

  • The MRQ is 3.457. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.457. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.457TTM3.4570.000
TTM3.457YOY3.918-0.461
TTM3.4575Y3.768-0.311
5Y3.76810Y3.875-0.107
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4572.348+1.109
TTM3.4572.437+1.020
YOY3.9182.184+1.734
5Y3.7682.409+1.359
10Y3.8752.407+1.468
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Universal Med Finl & generates.

  • Above 15 is considered overpriced but always compare Universal Med Finl & to the Credit Services industry mean.
  • A PE ratio of 4.02 means the investor is paying $4.02 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Universal Med Finl &:

  • The EOD is 4.302. Based on the earnings, the company is cheap. +2
  • The MRQ is 4.024. Based on the earnings, the company is cheap. +2
  • The TTM is 4.024. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD4.302MRQ4.024+0.278
MRQ4.024TTM4.0240.000
TTM4.024YOY4.744-0.719
TTM4.0245Y5.743-1.718
5Y5.74310Y8.038-2.295
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
EOD4.3028.927-4.625
MRQ4.0249.282-5.258
TTM4.0249.126-5.102
YOY4.7447.424-2.680
5Y5.7439.577-3.834
10Y8.03811.817-3.779
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Universal Med Finl &:

  • The EOD is 2.059. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 1.926. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 1.926. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD2.059MRQ1.926+0.133
MRQ1.926TTM1.9260.000
TTM1.926YOY5.749-3.823
TTM1.9265Y-2.076+4.002
5Y-2.07610Y-2.142+0.066
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
EOD2.0591.208+0.851
MRQ1.9261.270+0.656
TTM1.9261.596+0.330
YOY5.749-0.155+5.904
5Y-2.0760.874-2.950
10Y-2.1420.300-2.442
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Universal Med Finl & is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Credit Services industry mean).
  • A PB ratio of 0.39 means the investor is paying $0.39 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Universal Med Finl &:

  • The EOD is 0.414. Based on the equity, the company is cheap. +2
  • The MRQ is 0.387. Based on the equity, the company is cheap. +2
  • The TTM is 0.387. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.414MRQ0.387+0.027
MRQ0.387TTM0.3870.000
TTM0.387YOY0.533-0.146
TTM0.3875Y0.608-0.221
5Y0.60810Y0.932-0.323
Compared to industry (Credit Services)
PeriodCompanyIndustry (mean)+/- 
EOD0.4140.907-0.493
MRQ0.3870.949-0.562
TTM0.3870.959-0.572
YOY0.5330.932-0.399
5Y0.6081.152-0.544
10Y0.9321.357-0.425
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets80,344,744
Total Liabilities59,976,786
Total Stockholder Equity17,350,174
 As reported
Total Liabilities 59,976,786
Total Stockholder Equity+ 17,350,174
Total Assets = 80,344,744

Assets

Total Assets80,344,744
Total Current Assets30,695,176
Long-term Assets49,649,568
Total Current Assets
Cash And Cash Equivalents 3,539,945
Short-term Investments 56,777
Net Receivables 25,718,469
Inventory 431,141
Total Current Assets  (as reported)30,695,176
Total Current Assets  (calculated)29,746,332
+/- 948,844
Long-term Assets
Property Plant Equipment 5,552,876
Goodwill 286,538
Intangible Assets 161,266
Long-term Assets Other 625,652
Long-term Assets  (as reported)49,649,568
Long-term Assets  (calculated)6,626,332
+/- 43,023,236

Liabilities & Shareholders' Equity

Total Current Liabilities30,073,441
Long-term Liabilities29,903,345
Total Stockholder Equity17,350,174
Total Current Liabilities
Short Long Term Debt 22,453,360
Accounts payable 2,988,673
Total Current Liabilities  (as reported)30,073,441
Total Current Liabilities  (calculated)25,442,033
+/- 4,631,408
Long-term Liabilities
Long term Debt 24,866,077
Capital Lease Obligations Min Short Term Debt4,863,947
Long-term Liabilities Other 309,499
Long-term Liabilities  (as reported)29,903,345
Long-term Liabilities  (calculated)30,039,523
+/- 136,178
Total Stockholder Equity
Total Stockholder Equity (as reported)17,350,174
Total Stockholder Equity (calculated)0
+/- 17,350,174
Other
Capital Stock5,297,254
Common Stock Shares Outstanding 1,891,540
Net Debt 43,779,492
Net Invested Capital 64,669,611
Net Working Capital 621,735
Property Plant and Equipment Gross 6,971,604



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
5,883,444
10,452,434
16,385,316
23,657,881
28,964,583
37,732,513
47,256,927
57,852,542
61,511,013
69,899,801
76,870,771
80,344,744
80,344,74476,870,77169,899,80161,511,01357,852,54247,256,92737,732,51328,964,58323,657,88116,385,31610,452,4345,883,444
   > Total Current Assets 
0
10,150,908
4,759,911
7,963,122
8,975,980
11,927,479
14,660,581
20,714,278
21,832,527
64,511,260
69,495,118
30,695,176
30,695,17669,495,11864,511,26021,832,52720,714,27814,660,58111,927,4798,975,9807,963,1224,759,91110,150,9080
       Cash And Cash Equivalents 
307,980
318,998
453,569
1,865,670
1,272,458
1,749,884
2,173,473
3,385,867
2,036,535
2,342,078
3,457,729
3,539,945
3,539,9453,457,7292,342,0782,036,5353,385,8672,173,4731,749,8841,272,4581,865,670453,569318,998307,980
       Short-term Investments 
0
0
0
0
0
0
107,672
247,500
247,500
0
150,000
56,777
56,777150,0000247,500247,500107,672000000
       Net Receivables 
0
9,580,215
15,673,881
5,919,463
26,774,412
34,592,885
43,724,724
49,830,635
54,395,732
21,046,689
23,478,653
25,718,469
25,718,46923,478,65321,046,68954,395,73249,830,63543,724,72434,592,88526,774,4125,919,46315,673,8819,580,2150
       Other Current Assets 
0
248,374
100,685
139,678
674,080
943,706
566,148
562,182
725,782
1,089,576
937,607
0
0937,6071,089,576725,782562,182566,148943,706674,080139,678100,685248,3740
   > Long-term Assets 
0
0
0
0
19,988,603
25,805,034
32,596,346
37,138,264
39,678,486
44,907,169
48,779,838
49,649,568
49,649,56848,779,83844,907,16939,678,48637,138,26432,596,34625,805,03419,988,6030000
       Property Plant Equipment 
60,408
104,465
90,056
89,586
98,563
86,883
271,026
2,812,497
3,109,690
3,317,921
4,935,191
5,552,876
5,552,8764,935,1913,317,9213,109,6902,812,497271,02686,88398,56389,58690,056104,46560,408
       Goodwill 
0
0
0
0
0
9,211
9,211
69,908
69,908
102,253
102,253
286,538
286,538102,253102,25369,90869,9089,2119,21100000
       Long Term Investments 
0
0
20,955
64,916
64,916
43,961
81,250
481,761
0
0
0
0
0000481,76181,25043,96164,91664,91620,95500
       Intangible Assets 
0
0
0
0
0
9,211
132,134
0
58,603
46,183
79,173
161,266
161,26679,17346,18358,6030132,1349,21100000
       Long-term Assets Other 
0
0
0
0
3,396
4,678
9,953
44,559
58,603
6,910
19,801
625,652
625,65219,8016,91058,60344,5599,9534,6783,3960000
> Total Liabilities 
5,027,441
9,283,691
13,957,817
17,776,681
22,390,192
30,263,687
37,000,119
44,405,334
46,545,678
55,133,972
61,240,242
59,976,786
59,976,78661,240,24255,133,97246,545,67844,405,33437,000,11930,263,68722,390,19217,776,68113,957,8179,283,6915,027,441
   > Total Current Liabilities 
0
3,992,250
5,412,449
8,151,303
7,174,720
12,160,762
13,826,322
18,757,913
23,319,671
18,731,299
26,378,359
30,073,441
30,073,44126,378,35918,731,29923,319,67118,757,91313,826,32212,160,7627,174,7208,151,3035,412,4493,992,2500
       Short-term Debt 
0
7,911,623
3,379,351
4,252,442
6,083,374
10,863,858
107,672
247,500
19,150,093
3,877,871
2,518,976
0
02,518,9763,877,87119,150,093247,500107,67210,863,8586,083,3744,252,4423,379,3517,911,6230
       Short Long Term Debt 
0
7,911,623
3,379,351
4,252,442
6,083,374
10,863,858
12,025,566
13,786,425
19,150,093
13,625,659
19,994,848
22,453,360
22,453,36019,994,84813,625,65919,150,09313,786,42512,025,56610,863,8586,083,3744,252,4423,379,3517,911,6230
       Accounts payable 
547,054
234,597
956,422
94,773
194,333
264,697
482,381
1,289,436
868,396
1,111,983
2,247,218
2,988,673
2,988,6732,247,2181,111,983868,3961,289,436482,381264,697194,33394,773956,422234,597547,054
       Other Current Liabilities 
0
297,525
194,441
200,344
469,070
619,981
508,421
1,176,056
1,242,897
1,332,342
0
0
001,332,3421,242,8971,176,056508,421619,981469,070200,344194,441297,5250
   > Long-term Liabilities 
0
0
0
0
15,215,472
18,102,925
23,173,797
25,647,421
23,226,007
33,545,247
30,789,399
29,903,345
29,903,34530,789,39933,545,24723,226,00725,647,42123,173,79718,102,92515,215,4720000
       Long term Debt Total 
0
0
0
9,457,629
14,966,715
17,799,713
22,728,404
25,017,184
22,397,759
29,426,750
29,456,778
0
029,456,77829,426,75022,397,75925,017,18422,728,40417,799,71314,966,7159,457,629000
       Capital Lease Obligations Min Short Term Debt
0
-7,911,623
-3,379,351
-4,252,442
-5,881,845
-9,368,682
1,220,941
2,872,742
-16,976,016
-1,977,964
2,274,567
4,863,947
4,863,9472,274,567-1,977,964-16,976,0162,872,7421,220,941-9,368,682-5,881,845-4,252,442-3,379,351-7,911,6230
       Long-term Liabilities Other 
0
0
0
0
64,916
43,961
0
0
0
257,200
280,968
309,499
309,499280,968257,20000043,96164,9160000
> Total Stockholder Equity
856,003
1,168,743
2,427,499
5,881,200
6,574,391
7,468,601
10,048,092
11,141,691
12,422,901
14,765,829
15,630,529
17,350,174
17,350,17415,630,52914,765,82912,422,90111,141,69110,048,0927,468,6016,574,3915,881,2002,427,4991,168,743856,003
   Common Stock
775,291
775,291
1,579,905
4,327,842
4,327,842
4,327,842
4,327,842
4,327,842
4,327,842
5,297,254
5,297,254
0
05,297,2545,297,2544,327,8424,327,8424,327,8424,327,8424,327,8424,327,8421,579,905775,291775,291
   Retained Earnings 
80,517
393,255
841,629
1,524,110
2,183,999
3,078,209
4,078,048
5,159,574
6,352,994
7,705,246
9,016,746
0
09,016,7467,705,2466,352,9945,159,5744,078,0483,078,2092,183,9991,524,110841,629393,25580,517
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
0
197
5,965
29,248
62,550
62,550
1,642,202
1,654,275
1,742,065
1,763,329
1,316,529
0
01,316,5291,763,3291,742,0651,654,2751,642,20262,55062,55029,2485,9651970



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in HKD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue13,650,203
Cost of Revenue-9,078,344
Gross Profit4,571,8594,571,859
 
Operating Income (+$)
Gross Profit4,571,859
Operating Expense-10,418,371
Operating Income3,231,832-5,846,512
 
Operating Expense (+$)
Research Development-
Selling General Administrative1,565,604
Selling And Marketing Expenses-
Operating Expense10,418,3711,565,604
 
Net Interest Income (+$)
Interest Income84,129
Interest Expense-39,054
Other Finance Cost-0
Net Interest Income45,075
 
Pretax Income (+$)
Operating Income3,231,832
Net Interest Income45,075
Other Non-Operating Income Expenses-
Income Before Tax (EBT)2,866,2133,231,832
EBIT - interestExpense = -39,054
2,110,337
2,149,391
Interest Expense39,054
Earnings Before Interest and Taxes (EBIT)-2,905,267
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax2,866,213
Tax Provision-667,141
Net Income From Continuing Ops2,199,0722,199,072
Net Income2,110,337
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--45,075
 

Technical Analysis of Universal Med Finl &
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Universal Med Finl &. The general trend of Universal Med Finl & is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Universal Med Finl &'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Universal Med Finl &.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 5.18 < 5.87.

The bearish price targets are: 4.7933650197629 > 4.79 > 4.79.

Tweet this
Universal Med Finl & Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Universal Med Finl &. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Universal Med Finl & Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Universal Med Finl &. The current macd is 0.00076455.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Universal Med Finl & price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Universal Med Finl &. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Universal Med Finl & price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Universal Med Finl & Daily Moving Average Convergence/Divergence (MACD) ChartUniversal Med Finl & Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Universal Med Finl &. The current adx is 13.95.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Universal Med Finl & shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Universal Med Finl & Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Universal Med Finl &. The current sar is 5.157696.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Universal Med Finl & Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Universal Med Finl &. The current rsi is 43.29. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Universal Med Finl & Daily Relative Strength Index (RSI) ChartUniversal Med Finl & Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Universal Med Finl &. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Universal Med Finl & price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Universal Med Finl & Daily Stochastic Oscillator ChartUniversal Med Finl & Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Universal Med Finl &. The current cci is -116.66666667.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Universal Med Finl & Daily Commodity Channel Index (CCI) ChartUniversal Med Finl & Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Universal Med Finl &. The current cmo is -27.99216674.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Universal Med Finl & Daily Chande Momentum Oscillator (CMO) ChartUniversal Med Finl & Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Universal Med Finl &. The current willr is -97.43589744.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Universal Med Finl & Daily Williams %R ChartUniversal Med Finl & Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Universal Med Finl &.

Universal Med Finl & Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Universal Med Finl &. The current atr is 0.14403782.

Universal Med Finl & Daily Average True Range (ATR) ChartUniversal Med Finl & Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Universal Med Finl &. The current obv is 198,368,309.

Universal Med Finl & Daily On-Balance Volume (OBV) ChartUniversal Med Finl & Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Universal Med Finl &. The current mfi is 58.43.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Universal Med Finl & Daily Money Flow Index (MFI) ChartUniversal Med Finl & Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Universal Med Finl &.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-03MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.

6.3. Candlestick Patterns

Universal Med Finl & Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Universal Med Finl & based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.292
Ma 20Greater thanMa 504.954
Ma 50Greater thanMa 1004.844
Ma 100Greater thanMa 2004.600
OpenGreater thanClose4.890
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Universal Med Finl & with someone you think should read this too:
  • Are you bullish or bearish on Universal Med Finl &? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Universal Med Finl &? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Universal Med Finl &

I send you an email if I find something interesting about Universal Med Finl &.


Comments

How you think about this?

Leave a comment

Stay informed about Universal Med Finl &.

Receive notifications about Universal Med Finl & in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.